urocanic acid has been researched along with dinoprostone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finlay-Jones, JJ; Hart, PH; Jaksic, A; Santucci, I; Spencer, LK; Watson, CJ | 1 |
| Finlay-Jones, JJ; Hart, PH; Jones, CA; Jones, KL; Santucci, I; Spencer, LK; Watson, CJ | 1 |
| Bouscarel, B; Ceryak, S; DeFabo, EC; Gettys, TW; Noonan, F; Phillips, TM | 1 |
| Finlay-Jones, JJ; Hart, PH; Prêle, CM; Woodward, EA | 1 |
| John, S; Kaneko, K; Matsui, M; Norval, M; Smetana-Just, U; Walker, SL; Young, AR | 1 |
| Kaneko, K; Matsui, MS; Norval, M; Travers, JB; Walker, SL; Young, AR | 1 |
| Kaneko, K; Lai-Cheong, J; Matsui, MS; Norval, M; Walker, SL; Young, AR | 1 |
7 other study(ies) available for urocanic acid and dinoprostone
| Article | Year |
|---|---|
Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: link to indomethacin-inhibitable UVB-induced immunosuppression.
Topics: Animals; Dinoprostone; Drug Synergism; Female; Histamine; Histamine Antagonists; Humans; Immune System; Indomethacin; Keratinocytes; Mice; Mice, Inbred BALB C; Ultraviolet Rays; Urocanic Acid | 1995 |
Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels.
Topics: Brompheniramine; Cells, Cultured; Cimetidine; Cyclic AMP; Dinoprostone; Diphenhydramine; Histamine; Humans; In Vitro Techniques; Interleukin-1; Interleukin-6; Lipopolysaccharides; Monocytes; Pyrilamine; Second Messenger Systems; Stereoisomerism; Tumor Necrosis Factor-alpha; Urocanic Acid | 1993 |
Regulation of stimulated cyclic AMP synthesis by urocanic acid.
Topics: Adrenergic alpha-Agonists; Alprostadil; Animals; Brimonidine Tartrate; Cells, Cultured; Colon; Cricetinae; Cyclic AMP; Dinoprostone; Epinephrine; Fibroblasts; Histamine; HT29 Cells; Humans; Liver; Mesocricetus; Quinoxalines; Urocanic Acid | 1998 |
The receptor for cis-urocanic acid remains elusive.
Topics: Dinoprostone; Humans; Lipopolysaccharides; Receptors, Cell Surface; Serotonin; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Urocanic Acid | 2006 |
cis-Urocanic acid initiates gene transcription in primary human keratinocytes.
Topics: Adult; Cells, Cultured; Cytokines; Dinoprostone; Female; Gene Expression Regulation; Humans; Keratinocytes; Lipid Peroxidation; Male; Middle Aged; NF-kappa B; Transcription, Genetic; Urocanic Acid | 2008 |
cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors.
Topics: Cells, Cultured; Dinoprostone; Humans; Immune Tolerance; Interleukin-6; Isomerism; Keratinocytes; Metergoline; Platelet Membrane Glycoproteins; Receptor, Serotonin, 5-HT2A; Receptors, G-Protein-Coupled; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Transfection; Tumor Necrosis Factor-alpha; Urocanic Acid | 2009 |
cis-Urocanic acid enhances prostaglandin E2 release and apoptotic cell death via reactive oxygen species in human keratinocytes.
Topics: Apoptosis; Caspase 3; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Keratinocytes; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Urocanic Acid | 2011 |